百济神州暗藏杀招

药渡
Jul 12, 2025

在这个快速变化的时代,每一家创新药企都在竭尽全力的拼搏。例如,近日ADC龙头荣昌生物达成了一项NewCo出海交易:将核心产品泰它西普在大中华区以外的全球权益授予美国公司Vor Biopharma Inc.,将取得后者价值1.25亿美元现金及认股权证,最高可达41.05亿美元的临床注册及商业化里程碑付款,以及高个位数至双位数销售提成款。现阶段,荣昌生物正在不断寻求突围,争取早日实现扭亏为盈。而另一边...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10